Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease/Experiment 3

From BugSigDB


Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/12

Curated date: 2021/01/10

Curator: WikiWorks

Revision editor(s): Claregrieve1, WikiWorks

Subjects

Location of subjects
United States of America
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Psoriatic arthritis Arthritic Psoriasis,arthritis psoriatica,Arthritis, Psoriatic,arthropathic psoriasis,Psoriasis Arthropathica,Psoriasis, Arthritic,psoriatic arthritis,psoriatic arthritis, susceptibility to,psoriatic arthritis, susceptibility to, 1,psoriatic arthropathy,susceptibility to psoriatic arthritis,Psoriatic arthritis
Group 0 name Corresponds to the control (unexposed) group for case-control studies
skin psoriasis
Group 1 name Corresponds to the case (exposed) group for case-control studies
psoriatic arthiritis
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
patients fulfilling the psoriatic arthritis criteria of the Classification of Psoriatic arthritis (CASPAR)
Group 0 sample size Number of subjects in the control (unexposed) group
15
Group 1 sample size Number of subjects in the case (exposed) group
16
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
3 months

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V1-V2
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Roche454

Statistical Analysis

Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.2
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2
Matched on Factors on which subjects have been matched on in a case-control study
age, ethnic group, sex


Signature 1

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/12

Curated date: 2021/01/10

Curator: Rimsha Azhar

Revision editor(s): Claregrieve1, WikiWorks

Source: Figure 1c, Figure 2c

Description: Difference in bacterial taxa between psoriatic arthiritis compared to psoriasis samples

Abundance in Group 1: increased abundance in psoriatic arthiritis

NCBI Quality ControlLinks
Coprobacillus
unclassified Bacteroidota

Revision editor(s): Claregrieve1, WikiWorks

Signature 2

Needs review

Curated date: 2021/01/10

Curator: Rimsha Azhar

Revision editor(s): Claregrieve1, WikiWorks

Source: Figure 1c, Figure 2c

Description: Difference in bacterial taxa between psoriatic arthiritis compared to psoriasis samples

Abundance in Group 1: decreased abundance in psoriatic arthiritis

NCBI Quality ControlLinks
Clostridia
Eubacteriales
Bacillota
Verrucomicrobiota
Verrucomicrobiaceae

Revision editor(s): Claregrieve1, WikiWorks